• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Beech Tree Labs, Inc. - Product Pipeline Review - H2 2011 Product Image

Beech Tree Labs, Inc. - Product Pipeline Review - H2 2011

  • ID: 1925685
  • September 2011
  • 23 pages
  • Global Markets Direct

Beech Tree Labs, Inc. – Product Pipeline Review – H2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Beech Tree Labs, Inc. – Product Pipeline Review – H2 2011” provides data on the Beech Tree Labs, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Beech Tree Labs, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Beech Tree Labs, Inc. and industry–specific third party sources, put together by Global Markets Direct’s team.

Scope

- Beech Tree Labs, Inc. - Brief Beech Tree Labs, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Beech Tree Labs, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules READ MORE >



List of Tables
List of Figures
Beech Tree Labs, Inc. Snapshot
Beech Tree Labs, Inc. Overview
Key Information
Key Facts
Beech Tree Labs, Inc. – Research and Development Overview
Key Therapeutic Areas
Beech Tree Labs, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Beech Tree Labs, Inc. – Pipeline Products Glance
Beech Tree Labs, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Beech Tree Labs, Inc.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Beech Tree Labs, Inc. – Drug Profiles
Drug for Chronic Constipation
Product Description
Mechanism of Action
R&D Progress
Drug for Chronic Prostatitis
Product Description
Mechanism of Action
R&D Progress
Drug for Respiratory Disease
Product Description
Mechanism of Action
R&D Progress
Beech Tree Labs, Inc. – Pipeline Analysis
Beech Tree Labs, Inc. – Pipeline Products by Therapeutic Class
Beech Tree Labs, Inc. - Pipeline Products By Target
Beech Tree Labs, Inc. – Pipeline Products by Route of Administration
Beech Tree Labs, Inc. – Recent Pipeline Updates
Beech Tree Labs, Inc. - Dormant Projects
Beech Tree Labs, Inc. – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Jan 28, 2010: Beech Tree Announces US FDA Approval Of BTL-TML001
Sep 14, 2010: Beech Tree Labs Initiates Phase I/IIa Oral Herpes Trial
Apr 13, 2011: Beech Tree Labs Initiates Urinary Incontinence Trial
Jul 07, 2010: Beech Tree Labs Wins FDA Approval For Oral Herpes IND Application
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Beech Tree Labs, Inc. – Pipeline by Therapy Area and Indication, H2 2011
Beech Tree Labs, Inc. – Pipeline by Stage of Development, H2 2011
Beech Tree Labs, Inc. – Monotherapy Products in Pipeline, H2 2011
Beech Tree Labs, Inc. - Phase II, H2 2011
Beech Tree Labs, Inc. - Pipeline By Therapeutic Class, H2 2011
Beech Tree Labs, Inc. - Pipeline By Target, H2 2011
Beech Tree Labs, Inc. – Pipeline By Route of Administration, H2 2011
Beech Tree Labs, Inc. – Recent Pipeline Updates, H2 2011
Beech Tree Labs, Inc. - Dormant Developmental Projects, 2010
Beech Tree Labs, Inc., Other Locations

List of Figures
Beech Tree Labs, Inc. – Pipeline by Therapy Area and Indication, H2 2011
Beech Tree Labs, Inc. – Pipeline by Stage of Development, H2 2011
Beech Tree Labs, Inc. – Monotherapy Products in Pipeline, H2 2011
Beech Tree Labs, Inc. – Pipeline By Therapeutic Class, H2 2011

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos